Efficacy and Safety of Pueraria lobata Extract in Gray Hair Prevention: A Randomized, Double-Blind, Placebo-Controlled Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Graying of hair–a sign of aging–raises cosmetic concerns. Individuals with gray hair often look older than others their age; therefore, some dye their hair for aesthetic purposes. However, hair colorants can induce many problems including skin irritation, allergic reaction and hair-breakage. Objective: This randomized, double- blind clinical trial was performed in order to examine the effects of APHG-1001, a compound including an extract from Pueraria lobata, on graying hair. Methods: A total of 44female subjects were randomly treated with either APHG-1001 or placebo twice daily for 24 weeks. Using the phototrichogram analysis, a count of newly developed gray hair was estimated. Investigator assessment and subject self-assessment were also performed in order to evaluate the efficacy of the compound. Results: The mean number of newly developed gray hair at 24 weeks was 6.3/cm2 in the APHG-1001 group and 11.4/cm2 in the placebo group; the difference was statistically significant (p＜0.05). However,the investigator assessment and subject self-assessment did not show any significant change in the gross appearance of hair grayness by the end of the study. No severe adverse events in either group were observed. Moreover, the incidence of adverse events did not differ between the groups. Conclusion: This clinical trial revealed that APHG-1001, which contains an extract of P. lobata, could prevent the development of new gray hair without any remarkable adverse effects. Thus, it can be considered as a viable treatment option for the prevention of gray hair.
Abstract
Background: Graying of hair–a sign of aging–raises cosmetic concerns. Individuals with gray hair often look older than others their age; therefore, some dye their hair for aesthetic purposes. However, hair colorants can induce many problems including skin irritation, allergic reaction and hair-breakage. Objective: This randomized, double- blind clinical trial was performed in order to examine the effects of APHG-1001, a compound including an extract from Pueraria lobata, on graying hair. Methods: A total of 44female subjects were randomly treated with either APHG-1001 or placebo twice daily for 24 weeks. Using the phototrichogram analysis, a count of newly developed gray hair was estimated. Investigator assessment and subject self-assessment were also performed in order to evaluate the efficacy of the compound. Results: The mean number of newly developed gray hair at 24 weeks was 6.3/cm2 in the APHG-1001 group and 11.4/cm2 in the placebo group; the difference was statistically significant (p＜0.05). However,the investigator assessment and subject self-assessment did not show any significant change in the gross appearance of hair grayness by the end of the study. No severe adverse events in either group were observed. Moreover, the incidence of adverse events did not differ between the groups. Conclusion: This clinical trial revealed that APHG-1001, which contains an extract of P. lobata, could prevent the development of new gray hair without any remarkable adverse effects. Thus, it can be considered as a viable treatment option for the prevention of gray hair.
참고문헌 (16)
- Trüeb RM, "Aging of hair", J Cosmet Dermatol, 4, pp.60~72 (2005)
- Tobin DJ, "Graying: gerontobiology of the hair follicle pigmentary unit", Exp Gerontol, 36, pp.29~54 (2001)
- Keogh EV, "Rate of greying of human hair", Nature, 207, pp.877~878 (1965)
- Lapeere H, "Hypomelanoses and hypermelanoses, In Fitzpatrick's dermatology in general medicine. 7th ed", pp.622~640 (2008), McGraw-Hill Medical
- Cline DJ, "Changes in hair color", Dermatol Clin, 6, pp.295~303 (1988)
- Jo SJ, "Hair graying pattern depends on gender, onset age and smoking habits", Acta Derm Venereol, 92, pp.160~161 (2012)
- Bulpitt CJ, "Why do some people look older than they should?", Postgrad Med J, 77, pp.578~581 (2001)
- 조성진, "The Pattern of Hair Dyeing in Koreans with Gray Hair", Annals of Dermatology, 25(4), pp.401~404 (2013), 대한피부과학회
- Thyssen JP, "Epidemiological data on consumer allergy to p-phenylenediamine", Contact Dermatitis, 59, pp.327~343 (2008)
- Zhang YP, "Comparative evaluation of three methods based on high-performance liquid chromatography analysis combined with a 2,2'-diphenyl-1-picrylhydrazyl assayfor the rapid screening of antioxidants from Pueraria lobata flowers", Anal Bioanal Chem, 402, pp.2965~2976 (2012)
- Jiang RW, "A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis", J Ethnopharmacol, 96, pp.133~138 (2005)
- Cherdshewasart W, "Correlation of antioxidant activity and major isoflavonoid contents of the phytoestrogenrich Pueraria mirifica and Pueraria lobata tubers", Phytomedicine, 15, pp.38~43 (2008)
- Wood JM, "Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair", FASEB J, 23, pp.2065~2075 (2009)
- Arck PC, "Towards a "free radical theory of graying": melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage", FASEB J, 20, pp.1567~1569 (2006)
- Commo S, "Human hair greying is linked to a specific depletion of hair follicle melanocytes affecting both the bulb and the outer root sheath", Br J Dermatol, 150, pp.435~443 (2004)
- Bebrevska L, "In vivo antioxidative activity of a quantified Pueraria lobata root extract", J Ethnopharmacol, 127, pp.112~117 (2010)